Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount ... Novartis’ Sandoz generics arm, and Hikma have tried unsuccessfully to get ...

Mylan and Hikma, which has been working with Vectura, have also experienced pushback from the US regulator. Only yesterday, GlaxoSmithKline had warned investors that it expected a generic Advair ...

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Additionally, the minister provided an update on the Ras El-Hikma project, a large-scale development along Egypt’s Mediterranean coast. This ambitious project, which extends over an area of 40,600 ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

Hikma Health is an independent 501(c)(3) nonprofit making digital health systems and is not affiliated with Hikma Pharmaceuticals PLC or any of its affiliates.